Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 21, 2007; 13(7): 1098-1102
Published online Feb 21, 2007. doi: 10.3748/wjg.v13.i7.1098
Published online Feb 21, 2007. doi: 10.3748/wjg.v13.i7.1098
Table 1 Clinicopathological features of KIT-negative cases
CaseNo. | Sex | Age (yr) | Symptoms | Site | Size | Mitoses(/50 HPF) | Presenceof necrosis | Morphology | Risk category | Clinicalstatus | Survivaldata/mo |
(cm) | |||||||||||
1 | M | 60 | Yes | Small Intestine | 4.30 | 1 | No | Epithelioid | Low risk | Primary | Alive/12 |
2 | M | 46 | No | Stomach | 0.50 | 0 | No | Mixed | Very low risk | Primary | Alive/24 |
3 | M | 50 | No | Small Intestine | 0.50 | 0 | No | Anaplastic | Very low risk | Primary | Alive/24 |
4 | M | 64 | Yes | Large Intestine | 4.50 | 10 | Yes | Epithelioid | High risk | Liver metastasis | Dead/12 |
5 | M | 78 | Yes | Small Intestine | 7.00 | 1 | Yes | Mixed | Intermediate risk | Liver metastasis | Dead/12 |
6 | F | 53 | Yes | Stomach | 5.00 | 0 | No | Spindled | Low risk | Primary | Alive/47 |
7 | M | 43 | Yes | Esophagus | 7.00 | 0 | No | Mixed | Intermediate risk | Primary | Alive/25 |
8 | M | 51 | Yes | Small Intestine | 6.00 | 2 | Yes | Epithelioid | Intermediate risk | Primary | Alive/12 |
9 | M | 69 | No | Stomach | 2.00 | 0 | No | Mixed | Very low risk | Primary | Alive/37 |
10 | M | 54 | Yes | Stomach | 3.50 | 0 | No | Spindled | Low risk | Primary | Alive/62 |
11 | M | 70 | Yes | Stomach | 6.00 | 0 | No | Anaplastic | Intermediate risk | Primary | Alive/82 |
12 | M | 42 | Yes | Stomach | 6.00 | 2 | No | Anaplastic | Intermediate risk | Primary | Alive/56 |
13 | M | 26 | No | Stomach | 0.50 | 0 | No | Epithelioid | Very low risk | Primary | Alive/78 |
14 | M | 82 | Yes | Stomach | 30.00 | 6 | Yes | Mixed | High risk | Primary | Alive/82 |
15 | M | 61 | Yes | Small Intestine | 3.00 | 29 | No | Mixed | High risk | Liver metastasis | Dead/2 |
Table 2 Correlation between gender and CD117 expression in patients with GISTs
CD117 expression | ||||
Negative | Positive | Total | ||
Gender | Male | 14 | 17 | 31 |
45.20% | 54.80% | 100% | ||
Female | 1 | 18 | 19 | |
5.30% | 94.70% | 100% | ||
Total | 15 | 35 | 50 |
Table 3 Correlation between tumor location and CD117 expression in patients with GISTs
Tumor location | CD117 expression | |||
Negative | Positive | Total | ||
Esophagus | 1 | 2 | 3 | |
33.30% | 66.70% | 100% | ||
Stomach | 8 | 11 | 19 | |
42.10% | 57.90% | 100% | ||
Small intestine | 5 | 18 | 23 | |
21.70% | 78.30% | 100% | ||
Large intestine | 1 | 4 | 5 | |
20% | 80% | 100% | ||
Total | 15 | 35 | 50 | |
30% | 70% | 100% |
Table 4 Immunohistohemical findings of patients with KIT-negative GISTs
Immunohistochemistry | ||||||
CaseNo. | CD117 | α-SMA | Desmin | S-100 | NSE | CD34 |
1 | Negative | Positive | Positive | - | - | Positive |
2 | Negative | - | Positive | Positive | - | - |
3 | Negative | - | - | - | - | Positive |
4 | Negative | Positive | - | - | - | Positive |
5 | Negative | Positive | - | - | Positive | - |
6 | Negative | - | - | Positive | Positive | - |
7 | Negative | Positive | Positive | Positive | - | - |
8 | Negative | Positive | - | - | - | Positive |
9 | Negative | Positive | Positive | - | Positive | - |
10 | Negative | - | - | Positive | Positive | Positive |
11 | Negative | - | - | - | - | Positive |
12 | Negative | - | - | - | - | Positive |
13 | Negative | Positive | Positive | - | - | - |
14 | Negative | Positive | - | - | Positive | Positive |
15 | Negative | Positive | - | Positive | - | - |
- Citation: Kontogianni-Katsarou K, Lariou C, Tsompanaki E, Vourlakou C, Kairi-Vassilatou E, Mastoris C, Pantazi G, Kondi-Pafiti A. KIT-negative gastrointestinal stromal tumors with a long term follow-up: A new subgroup does exist. World J Gastroenterol 2007; 13(7): 1098-1102
- URL: https://www.wjgnet.com/1007-9327/full/v13/i7/1098.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i7.1098